Research output: Contribution to Journal/Magazine › Journal article › peer-review
Research output: Contribution to Journal/Magazine › Journal article › peer-review
}
TY - JOUR
T1 - TNF-α mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's β-Amyloid oligomers in mice and monkeys
AU - Lourenco, Mychael V.
AU - Clarke, Julia R.
AU - Frozza, Rudimar L.
AU - Bomfim, Theresa R.
AU - Forny-Germano, Letícia
AU - Batista, André F.
AU - Sathler, Luciana B.
AU - Brito-Moreira, Jordano
AU - Amaral, Olavo B.
AU - Silva, Cesar A.
AU - Freitas-Correa, Léo
AU - Espírito-Santo, Sheila
AU - Campello-Costa, Paula
AU - Houzel, Jean-Christophe
AU - Klein, William L.
AU - Holscher, Christian
AU - Carvalheira, José B.
AU - Silva, Aristobolo M.
AU - Velloso, Lício A.
AU - Munoz, Douglas P.
AU - Ferreira, Sergio T.
AU - De Felice, Fernanda G.
PY - 2013/12/3
Y1 - 2013/12/3
N2 - Alzheimer's disease (AD) and type 2 diabetes appear to share similar pathogenic mechanisms. dsRNA-dependent protein kinase (PKR) underlies peripheral insulin resistance in metabolic disorders. PKR phosphorylates eukaryotic translation initiation factor 2α (eIF2α-P), and AD brains exhibit elevated phospho-PKR and eIF2α-P levels. Whether and how PKR and eIF2α-P participate in defective brain insulin signaling and cognitive impairment in AD are unknown. We report that β-amyloid oligomers, AD-associated toxins, activate PKR in a tumor necrosis factor α (TNF-α)-dependent manner, resulting in eIF2α-P, neuronal insulin receptor substrate (IRS-1) inhibition, synapse loss, and memory impairment. Brain phospho-PKR and eIF2α-P were elevated in AD animal models, including monkeys given intracerebroventricular oligomer infusions. Oligomers failed to trigger eIF2α-P and cognitive impairment in PKR(-/-) and TNFR1(-/-) mice. Bolstering insulin signaling rescued phospho-PKR and eIF2α-P. Results reveal pathogenic mechanisms shared by AD and diabetes and establish that proinflammatory signaling mediates oligomer-induced IRS-1 inhibition and PKR-dependent synapse and memory loss.
AB - Alzheimer's disease (AD) and type 2 diabetes appear to share similar pathogenic mechanisms. dsRNA-dependent protein kinase (PKR) underlies peripheral insulin resistance in metabolic disorders. PKR phosphorylates eukaryotic translation initiation factor 2α (eIF2α-P), and AD brains exhibit elevated phospho-PKR and eIF2α-P levels. Whether and how PKR and eIF2α-P participate in defective brain insulin signaling and cognitive impairment in AD are unknown. We report that β-amyloid oligomers, AD-associated toxins, activate PKR in a tumor necrosis factor α (TNF-α)-dependent manner, resulting in eIF2α-P, neuronal insulin receptor substrate (IRS-1) inhibition, synapse loss, and memory impairment. Brain phospho-PKR and eIF2α-P were elevated in AD animal models, including monkeys given intracerebroventricular oligomer infusions. Oligomers failed to trigger eIF2α-P and cognitive impairment in PKR(-/-) and TNFR1(-/-) mice. Bolstering insulin signaling rescued phospho-PKR and eIF2α-P. Results reveal pathogenic mechanisms shared by AD and diabetes and establish that proinflammatory signaling mediates oligomer-induced IRS-1 inhibition and PKR-dependent synapse and memory loss.
U2 - 10.1016/j.cmet.2013.11.002
DO - 10.1016/j.cmet.2013.11.002
M3 - Journal article
C2 - 24315369
VL - 18
SP - 831
EP - 843
JO - Cell Metabolism
JF - Cell Metabolism
SN - 1932-7420
IS - 6
ER -